Ananda K. Kanduluru

2016- On Target Laboratory 
"Ananda Kanduluru"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kanduluru AK, Srinivasarao M, Wayua C, et al. (2019) Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging
Lee YG, Marks I, Srinivasarao M, et al. (2018) Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors. Cancer Research
Zhang H, Kanduluru AK, Desai P, et al. (2018) Synthesis and evaluation of a novelCu/Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts. Bioconjugate Chemistry
Kanduluru AK, Low PS. (2017) Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers. Molecular Pharmaceutics
Kanduluru AK, Srinivasarao M, Low PS. (2016) Design, Synthesis and Evaluation of a Neurokinin 1 Receptor-Targeted Near IR Dye for Fluorescence Guided Surgery of Neuroendocrine Cancers. Bioconjugate Chemistry
Roy J, Nguyen TX, Kanduluru AK, et al. (2015) DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selective prostate cancer cell targeting. Journal of Medicinal Chemistry. 58: 3094-103
See more...